Literature DB >> 21866186

Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents.

Daniela Kracht1, Rukshana Shroff, Sabrina Baig, Anke Doyon, Christoph Jacobi, Rene Zeller, Uwe Querfeld, Franz Schaefer, Elke Wühl, Bernhard M W Schmidt, Anette Melk.   

Abstract

BACKGROUND: Pulse wave velocity (PWV) is an indicator of aortic stiffness and a predictor of cardiovascular risk. Applanation tonometry (e.g., SphygmoCor) is a well-established method to measure aortic PWV (aPWV). The Vicorder, a new oscillometric device, has not been validated in children and adolescents.
METHODS: We performed intra- and interobserver repeatability studies in 14 individuals using the Vicorder. Vicorder and SphygmoCor measurements were compared in 156 healthy children (6-18 years) using two different path length measurements.
RESULTS: Intra- and interobserver repeatabilities of the Vicorder were excellent with coefficients of variation of 5.6% and 5.8% and intraclass correlation coefficients (ICCs) of 0.8 and 1.0. aPWV calculated using the distances (suprasternal notch-to-femoral recording point) - (suprasternal notch-to-carotid artery), the path length most commonly used in adults, revealed a mean of 4.8 ± 0.7 m/s for SphygmoCor and 4.9 ± 0.6 m/s for Vicorder. The percentage deviation between both devices was 13.0% and the limit of agreement (LoA) ranged from -1.0 to 1.7 m/s reflecting a good concordance. Using a path length that measured the distance from suprasternal notch to femoral recording point via the umbilicus (Umb), an even better agreement was found (percentage deviation: 11.8%, LoA: -1.0 to 1.6 m/s).
CONCLUSIONS: Vicorder aPWV values are similar to those obtained by SphygmoCor applanation tonometry. The best agreement between devices was obtained with the path length that most accurately describes the aortic tree. Excellent intra- and interobserver repeatability and ease of measurements make Vicorder appropriate for large multicentre studies in children and adolescents.

Entities:  

Mesh:

Year:  2011        PMID: 21866186     DOI: 10.1038/ajh.2011.147

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  32 in total

1.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

2.  Factors associated with cardiovascular target organ damage in children after renal transplantation.

Authors:  Bianca Borchert-Mörlins; Daniela Thurn; Bernhard M W Schmidt; Anja K Büscher; Jun Oh; Tanja Kier; Elena Bauer; Sabrina Baig; Nele Kanzelmeyer; Markus J Kemper; Rainer Büscher; Anette Melk
Journal:  Pediatr Nephrol       Date:  2017-08-13       Impact factor: 3.714

3.  Cardiovascular Phenotypes in Children with CKD: The 4C Study.

Authors:  Franz Schaefer; Anke Doyon; Karolis Azukaitis; Aysun Bayazit; Nur Canpolat; Ali Duzova; Ana Niemirska; Betul Sözeri; Daniela Thurn; Ali Anarat; Bruno Ranchin; Mieczyslav Litwin; Salim Caliskan; Cengiz Candan; Esra Baskin; Ebru Yilmaz; Sevgi Mir; Marietta Kirchner; Anja Sander; Dieter Haffner; Anette Melk; Elke Wühl; Rukshana Shroff; Uwe Querfeld
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-08       Impact factor: 8.237

Review 4.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

5.  The interplay between bone and vessels in pediatric CKD: lessons from a single-center study.

Authors:  Evgenia Preka; Bruno Ranchin; Anke Doyon; Melody Vierge; Tiphanie Ginhoux; Behrouz Kassai; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2018-06-05       Impact factor: 3.714

Review 6.  Cardiovascular risk assessment in children with chronic kidney disease.

Authors:  Rukshana Shroff; Arianna Dégi; Andrea Kerti; Eva Kis; Orsolya Cseprekál; Kálmán Tory; Attila J Szabó; George S Reusz
Journal:  Pediatr Nephrol       Date:  2012-10-16       Impact factor: 3.714

7.  Arterial stiffness is increased in asthmatic children.

Authors:  Markus Steinmann; Chiara Abbas; Florian Singer; Carmen Casaulta; Nicolas Regamey; Dieter Haffner; Dagmar-Christiane Fischer; Giacomo D Simonetti
Journal:  Eur J Pediatr       Date:  2014-09-25       Impact factor: 3.183

8.  Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome.

Authors:  Cengiz Candan; Nur Canpolat; Selman Gökalp; Nurdan Yıldız; Pınar Turhan; Mehmet Taşdemir; Lale Sever; Salim Çalışkan
Journal:  Pediatr Nephrol       Date:  2013-09-15       Impact factor: 3.714

Review 9.  Cardiovascular risk factors in children on dialysis: an update.

Authors:  Uwe Querfeld; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2018-10-31       Impact factor: 3.714

10.  Arteriosclerosis and arterial remodeling; different mechanisms in young adults.

Authors:  Antonios A Argyris; Dimitrios A Vrachatis; Theodore G Papaioannou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.